# BOTOX® Treatment in Pediatric Upper Limb Spasticity

> **NCT01603602** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 235 (actual)

## Conditions studied

- Pediatrics
- Muscle Spasticity
- Cerebral Palsy
- Stroke

## Interventions

- **BIOLOGICAL:** botulinum toxin Type A
- **DRUG:** Normal Saline (Placebo)

## Key facts

- **NCT ID:** NCT01603602
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-12
- **Primary completion:** 2017-06-29
- **Final completion:** 2017-07-06
- **Target enrollment:** 235 (ACTUAL)
- **Last updated:** 2018-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01603602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01603602, "BOTOX® Treatment in Pediatric Upper Limb Spasticity". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01603602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*